BUZZ-BioCryst Pharmaceuticals 季度收入不及预期,业绩下滑

路透中文
Nov 04, 2025
BUZZ-BioCryst Pharmaceuticals 季度收入不及预期,业绩下滑

11月3日 - ** 制药公司BioCryst Pharmaceuticals BCRX.O股价下跌4%,报7.03美元。

** (link) 公布的第三季度营收为1.594亿美元,低于分析师预计的1.63亿美元--数据由LSEG编制

** BCRX将其皮肤病药物orladeyo的2025年收入预期从5.8亿至6亿美元下调至5.9亿至6亿美元。

** 截至收盘股价累计下跌近3

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10